Drug · DIN 02451816
BRIDION
2 ML AND 5 ML SINGLE-USE VIALS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 19, 2016; first marketed February 19, 2016.
- Drug Identification Number (DIN)
- 02451816
- Company (DIN owner)
- Merck Canada IncKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Sugammadex V03AB35
- Class
- Human
- Record last updated
- August 6, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SUGAMMADEX (SUGAMMADEX SODIUM) | 100 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 5, 2016: NOC 17744New Drug Submission (NDS)